- Resistance to Immunotherapeutic Antibodies in Cancer
- Springer New York
- Published Date:
- Paperback / softback
- Product Dim.:
- 9.25 H x 6.10 W (inches)
Resistance to Immunotherapeutic Antibodies in Cancer
â€‹â€‹â€‹â€‹The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance.Â Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book coversÂ the commonÂ and unique features of mAbs agains various cancer,Â gives the latest developments onÂ the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.
Special Offers and Promotions
Our print to order bookstore saves you money. There are currently no special offers for Resistance to Immunotherapeutic Antibodies in Cancer
Thank you for selecting our online bookstore. Currently, there are no editorial book reviews for Resistance to Immunotherapeutic Antibodies in Cancer
About Pubgraphics Direct
PGDirect is an online bookstore that has embraced the concept of direct to consumer selling for self-published books, softcover and hardcover books, specialty books, children's books, hard to find books, college textbooks, print on demand books and more.